Professional regulation: a potentially valuable tool in responding to "stem cell tourism"
- PMID: 25241736
- PMCID: PMC4266009
- DOI: 10.1016/j.stemcr.2014.06.016
Professional regulation: a potentially valuable tool in responding to "stem cell tourism"
Abstract
The growing international market for unproven stem cell-based interventions advertised on a direct-to-consumer basis over the internet ("stem cell tourism") is a source of concern because of the risks it presents to patients as well as their supporters, domestic health care systems, and the stem cell research field. Emerging responses such as public and health provider-focused education and national regulatory efforts are encouraging, but the market continues to grow. Physicians play a number of roles in the stem cell tourism market and, in many jurisdictions, are members of a regulated profession. In this article, we consider the use of professional regulation to address physician involvement in stem cell tourism. Although it is not without its limitations, professional regulation is a potentially valuable tool that can be employed in response to problematic types of physician involvement in the stem cell tourism market.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
International stem cell tourism: a critical literature review and evidence-based recommendations.Int Health. 2022 Mar 2;14(2):132-141. doi: 10.1093/inthealth/ihab050. Int Health. 2022. PMID: 34415026 Free PMC article. Review.
-
Unproven stem cell-based interventions & physicians' professional obligations; a qualitative study with medical regulatory authorities in Canada.BMC Med Ethics. 2014 Oct 14;15:75. doi: 10.1186/1472-6939-15-75. BMC Med Ethics. 2014. PMID: 25315976 Free PMC article.
-
What's missing? Discussing stem cell translational research in educational information on stem cell "tourism".J Law Med Ethics. 2013 Spring;41(1):254-68. doi: 10.1111/jlme.12017. J Law Med Ethics. 2013. PMID: 23581669
-
From the margins to mainstream: How providers of autologous 'stem cell treatments' legitimise their practice in Australia.Health (London). 2021 Jan;25(1):51-68. doi: 10.1177/1363459319846927. Epub 2019 May 13. Health (London). 2021. PMID: 31081381
-
Allogeneic Mesenchymal Stem Cell-Based Treatment Legislation in Latin America: The Need for Standardization in a Medical Tourism Context.Stem Cells Dev. 2022 Apr;31(7-8):143-162. doi: 10.1089/scd.2022.0013. Epub 2022 Mar 25. Stem Cells Dev. 2022. PMID: 35216516 Review.
Cited by
-
Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.BMJ Open. 2018 Feb 28;8(2):e019414. doi: 10.1136/bmjopen-2017-019414. BMJ Open. 2018. PMID: 29490963 Free PMC article.
-
"That's enough patients for everyone!": Local stakeholders' views on attracting patients into Barbados and Guatemala's emerging medical tourism sectors.Global Health. 2016 Oct 7;12(1):60. doi: 10.1186/s12992-016-0203-7. Global Health. 2016. PMID: 27717389 Free PMC article.
-
Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain.PLoS One. 2019 Apr 3;14(4):e0214950. doi: 10.1371/journal.pone.0214950. eCollection 2019. PLoS One. 2019. PMID: 30943248 Free PMC article. Clinical Trial.
-
International stem cell tourism: a critical literature review and evidence-based recommendations.Int Health. 2022 Mar 2;14(2):132-141. doi: 10.1093/inthealth/ihab050. Int Health. 2022. PMID: 34415026 Free PMC article. Review.
-
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies.Stem Cells Transl Med. 2015 Apr;4(4):389-400. doi: 10.5966/sctm.2014-0110. Epub 2015 Feb 26. Stem Cells Transl Med. 2015. PMID: 25722427 Free PMC article. Review.
References
-
- Arellano M. The rise of stem cell therapies in Mexico: inadequate regulation or unsuccessful oversight? Rev. Redbio. UNESCO. 2012;2:63–78.
-
- Berfield, S. (2013). CellTex says it’s moving its stem cell business to Mexico. Bloomberg Businessweek, January 31, 2013. http://www.businessweek.com/articles/2013-01-31/celltex-wants-to-bring-i....
-
- Bianco P., Sipp D. Regulation: sell help not hope. Nature. 2014;509:336–337. - PubMed
-
- Bourgeault I., Grignon M. A comparison of the regulation of health professional boundaries across OECD countries. Eur. J. Comp. Econ. 2013;10:199–223.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources